Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

HER2-positiv metastatisk brystkræft

Research output: Contribution to journalReviewResearchpeer-review

  1. Orbital cysticercosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Palytoksinforgiftning relateret til saltvandsakvarie

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Presence of SARS-CoV-2 in semen and the impact of COVID-19 on the male reproductive system

    Research output: Contribution to journalReviewResearchpeer-review

  4. Flying fattens and swimming slims - the secret of the mermaid

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Behandling af mandlig infertilitet

    Research output: Contribution to journalReviewResearchpeer-review

  1. Mortality from cardiovascular disease in women with breast cancer - a nationwide registry study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiovascular disease in women with breast cancer - a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Breast cancer is the most common type of cancer among women in Denmark. In 15% of the patients with metastatic breast cancer (mBC) an overexpression of the HER2 protein on the tumour cells, amplification of the HER2-gene or both are present. HER2-positive mBC is associated with poor disease prognosis. The discovery of HER2 led to the development of HER2-targeting monoclonal antibodies significantly improving survival for patients with HER2-positive mBC as summarised in this review. The future brings even more HER2-targeting drugs, which further can contribute to the palliative treatment of HER2-postive mBC patients.

Translated title of the contributionTargeted treatment of HER2-positive metastatic breast cancer improves prognosis significantly
Original languageDanish
JournalUgeskrift for Laeger
Volume183
Issue number26
Pages (from-to)V12200938
ISSN0041-5782
Publication statusPublished - 28 Jun 2021

ID: 68601334